Endoscopic and Histologic Response and Remission in Inflammatory Bowel Disease Patients Initiating Vedolizumab

被引:2
|
作者
Christensen, Britt [1 ]
Rubin, David T. [1 ]
Goeppinger, Sarah [1 ]
Colman, Ruben J. [1 ]
Yarur, Andres [1 ]
Hirsch, Ayal [1 ]
Bocheneck, Ashley [1 ]
Wichmann, Alana [1 ]
Sakuraba, Atsushi [2 ]
Cohen, Russell [1 ]
Siddiqui, Dania [1 ]
机构
[1] Univ Chicago Med, Chicago, IL USA
[2] Univ Chicago, Chicago, IL 60637 USA
来源
关键词
D O I
10.14309/00000434-201510001-01843
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1843
引用
收藏
页码:S783 / S784
页数:2
相关论文
共 50 条
  • [31] EFFECT OF VEDOLIZUMAB DOSE ESCALATION ON RECAPTURING RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Shivashankar, Raina
    Ladd, Antonio H. Mendoza
    Grace, Rory
    Aberra, Faten
    Lichtenstein, Gary R.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S77 - S77
  • [32] VEDOLIZUMAB DOSE ESCALATION AS A WAY OF RECAPTURING RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Birdi, S.
    Sierra Morales, M.
    Samaan, M. A.
    Brown-Clarke, C.
    Stanton, A.
    Ray, S.
    Koumoutsos, I.
    Mawdsley, J.
    Anderson, S.
    Sandersdon
    Irving, P. M.
    [J]. GUT, 2018, 67 : A69 - A70
  • [33] METHOTREXATE INDUCES CLINICAL AND HISTOLOGIC REMISSION IN PATIENTS WITH REFRACTORY INFLAMMATORY BOWEL-DISEASE
    KOZAREK, RA
    PATTERSON, DJ
    GELFAND, MD
    BOTOMAN, VA
    BALL, TJ
    WILSKE, KR
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 110 (05) : 353 - 356
  • [34] Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients
    Lin, Wei-Chen
    Wong, Jau-Min
    Tung, Chien-Chih
    Lin, Ching-Pin
    Chou, Jen-Wei
    Wang, Horng-Yuan
    Shieh, Ming-Jium
    Chang, Chin-Hao
    Liu, Heng-Hsiu
    Wei, Shu-Chen
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (48) : 13566 - 13573
  • [35] Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients
    Wei-Chen Lin
    Jau-Min Wong
    Chien-Chih Tung
    Ching-Pin Lin
    Jen-Wei Chou
    Horng-Yuan Wang
    Ming-Jium Shieh
    Chin-Hao Chang
    Heng-Hsiu Liu
    Shu-Chen Wei
    [J]. World Journal of Gastroenterology, 2015, (48) : 13566 - 13573
  • [36] SAFETY OF VEDOLIZUMAB USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Shivashankar, Raina
    Ladd, Antonio H. Mendoza
    Grace, Rory
    Aberra, Faten
    Lichtenstein, Gary R.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S585 - S585
  • [37] Vedolizumab Use in Pediatric Patients With Inflammatory Bowel Disease
    Singh, Namita
    Patel, Minesh
    Rabizadeh, Shervin
    Dubinsky, Marla
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S72 - S72
  • [38] Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study
    Martin, Antoine
    Nachury, Maria
    Peyrin-Biroulet, Laurent
    Bouhnik, Yoram
    Nancey, Stephane
    Bourrier, Anne
    Serrero, Melanie
    Fumery, Mathurin
    Buisson, Anthony
    Laharie, David
    Gilletta, Cyrielle
    Filippi, Jerome
    Allez, Matthieu
    Bouguen, Guillaume
    Roblin, Xavier
    Altwegg, Romain
    Dib, Nina
    de Chambrun, Guillaume Pineton
    Savoye, Guillaume
    Carbonnel, Franck
    Viennot, Stephanie
    Amiot, Aurelien
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 (07): : 896 - 903
  • [39] vedolizumab trough levels at week 6 and 14 correlate with clinical remission in inflammatory bowel disease patients
    Marino, M.
    Domenis, R.
    Biribin, L.
    Cifu, A.
    Navarria, L.
    Scardino, G.
    Fabris, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S492 - S492
  • [40] Vedolizumab Levels During Induction Are Associated With Remission in Patients With Inflammatory Bowel Diseases
    Yarur, Andres
    Bruss, Alexandra
    Patel, Amir
    Beniwal-Patel, Poonam
    Fox, Caroline
    Ungaro, Ryan
    Dubinsky, Marla C.
    Naik, Snehal
    Stein, Daniel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S353 - S354